Gefitinib 250 Mg | Getinib | gefitinib mechanism of action

Getinib 250 mg is used for the patients with advanced non-small cell lung cancer (NSCLC) that hase spread. It is intended for patients whose tumors have specific mutations in the epidermal growth factor receptor (EGFR).